Marshall & Sullivan Inc Becton Dickinson & CO Transaction History

Marshall & Sullivan Inc

$198 Million
Q3 2024

A detailed history of Marshall & Sullivan Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Marshall & Sullivan Inc holds 18,763 shares of BDX stock, worth $4.29 Million. This represents 2.28% of its overall portfolio holdings.

Number of Shares

18,763

Previous 18,856 0.49%

Holding current value

$4.29 Million

Previous $4.41 Million 2.66%

% of portfolio

2.28%

Previous 2.3%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$221.47 - $242.41 $20,596 - $22,544	-93 Reduced 0.49%	18,763 $4.52 Million
Q2 2024 Jul 12, 2024	SELL	$225.07 - $246.17 $41,412 - $45,295	-184 Reduced 0.97%	18,856 $4.41 Million
Q1 2024 Apr 10, 2024	BUY	$233.45 - $247.73 $10,738 - $11,395	46 Added 0.24%	19,040 $4.71 Million
Q4 2023 Jan 11, 2024	SELL	$232.24 - $267.23 $7,431 - $8,551	-32 Reduced 0.17%	18,994 $4.63 Million
Q3 2023 Oct 06, 2023	SELL	$254.9 - $283.59 $52,509 - $58,419	-206 Reduced 1.07%	19,026 $4.92 Million
Q2 2023 Jul 12, 2023	BUY	$238.39 - $265.32 $67,702 - $75,350	284 Added 1.5%	19,232 $5.08 Million
Q1 2023 Apr 10, 2023	BUY	$229.71 - $259.35 $68,683 - $77,545	299 Added 1.6%	18,948 $4.69 Million
Q4 2022 Jan 18, 2023	SELL	$218.29 - $256.91 $80,112 - $94,285	-367 Reduced 1.93%	18,649 $0
Q3 2022 Oct 28, 2022	BUY	$51.03 - $264.23 $3,061 - $15,853	60 Added 0.32%	19,016 $4.24 Million
Q2 2022 Jul 06, 2022	BUY	$234.74 - $275.42 $27,699 - $32,499	118 Added 0.63%	18,956 $4.67 Million
Q1 2022 May 02, 2022	SELL	$243.64 - $270.48 $184,191 - $204,482	-756 Reduced 3.86%	18,838 $5.01 Million
Q4 2021 Jan 24, 2022	BUY	$230.08 - $250.94 $53,608 - $58,469	233 Added 1.2%	19,594 $4.93 Million
Q3 2021 Oct 19, 2021	BUY	$232.72 - $256.47 $220,618 - $243,133	948 Added 5.15%	19,361 $4.76 Million
Q2 2021 Aug 09, 2021	BUY	$232.65 - $254.58 $65,142 - $71,282	280 Added 1.54%	18,413 $4.48 Million
Q1 2021 May 04, 2021	BUY	$232.09 - $256.88 $3.18 Million - $3.52 Million	13,710 Added 309.97%	18,133 $4.41 Million
Q4 2020 Jan 29, 2021	SELL	$221.92 - $245.94 $2.89 Million - $3.2 Million	-13,004 Reduced 74.62%	4,423 $17.7 Million
Q3 2020 Nov 02, 2020	BUY	$215.77 - $276.76 $40,348 - $51,754	187 Added 1.08%	17,427 $4.06 Million
Q2 2020 Jul 14, 2020	SELL	$219.9 - $263.41 $16,052 - $19,228	-73 Reduced 0.42%	17,240 $4.13 Million
Q1 2020 May 06, 2020	SELL	$195.69 - $279.01 $245,982 - $350,715	-1,257 Reduced 6.77%	17,313 $3.98 Million
Q4 2019 Jan 14, 2020	SELL	$236.45 - $266.82 $31,211 - $35,220	-132 Reduced 0.71%	18,570 $5.05 Million
Q3 2019 Oct 11, 2019	SELL	$230.58 - $256.08 $2,075 - $2,304	-9 Reduced 0.05%	18,702 $4.73 Million
Q2 2019 Aug 05, 2019	SELL	$217.4 - $246.08 $33,044 - $37,404	-152 Reduced 0.81%	18,711 $4.72 Million
Q1 2019 May 08, 2019	BUY	$206.05 - $248.17 $43,270 - $52,115	210 Added 1.13%	18,863 $4.71 Million
Q4 2018 Jan 28, 2019	SELL	$204.73 - $257.93 $140,035 - $176,424	-684 Reduced 3.54%	18,653 $4.2 Million
Q3 2018 Oct 29, 2018	BUY	$233.07 - $256.0 $15,382 - $16,896	66 Added 0.34%	19,337 $5.05 Million
Q2 2018 Jul 31, 2018	BUY	$208.1 - $233.85 $50,984 - $57,293	245 Added 1.29%	19,271 $0
Q1 2018 Apr 30, 2018	SELL	$205.46 - $240.27 $235,457 - $275,349	-1,146 Reduced 5.68%	19,026 $4.12 Million
Q4 2017 Feb 09, 2018	SELL	$189.0 - $222.64 $62,937 - $74,139	-333 Reduced 1.62%	20,172 $4.32 Million
Q3 2017 Nov 09, 2017	SELL	$186.89 - $198.9 $15,138 - $16,110	-81 Reduced 0.39%	20,505 $4.28 Million
Q2 2017 Aug 09, 2017	BUY	N/A	20,586	20,586 $4.02 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall & Sullivan Inc , based on Form 13F filings with the SEC.

News

Stay updated on Marshall & Sullivan Inc with notifications on news.

Account

Marshall & Sullivan Inc Becton Dickinson & CO Transaction History